A+ | A | A- | Skip to main content |

800 years stamp

Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Wednesday, 07 October 2026 12:00 AM EOD	Asian-Paints2370.00	Hind-Unilever1868.00	ITC265.30	Trent2888.00	Larsen-and-Toubro3699.00	M-and-M2804.95	Reliance-Industries1206.65	Tata-Steel175.50	Titan-Company4380.00	SBI952.80	Bharat-Electron378.85	Kotak-Mah-Bank440.80	Infosys992.10	Bajaj-Finance964.10	Sun-PharmaInds1783.25	HDFC-Bank703.80	TCS2084.00	ICICI-Bank1357.00	Power-Grid-Corpn253.40	Maruti-Suzuki11489.85	Axis-Bank1243.90	HCL-Technologies1183.80	NTPC317.00	Bharti-Airtel1833.00	Tech-Mahindra1489.10	Adani-Ports1748.10	UltraTech-Cem10693.85	Bajaj-Finserv1741.00	Interglobe-Aviat4980.25	Eternal327.80
15 mins delay SENSEX 72,638.70 [-429.11]	-50.00 -2.07%	-24.10 -1.27%	-1.20 -0.45%	-16.00 -0.55%	-74.00 -1.96%	-47.05 -1.65%	-12.35 -1.01%	-3.10 -1.74%	-160.00 -3.52%	-4.45 -0.46%	-8.55 -2.21%	9.55 2.21%	-20.90 -2.06%	2.30 0.24%	-17.75 -0.99%	-6.40 -0.90%	-14.00 -0.67%	15.40 1.15%	-3.60 -1.40%	-113.15 -0.98%	-4.60 -0.37%	-18.30 -1.52%	-4.30 -1.34%	24.00 1.33%	-13.90 -0.92%	-33.90 -1.90%	-103.00 -0.95%	-12.45 -0.71%	-64.75 -1.28%	-0.25 -0.08%

Corporate Results

Profit or loss trends for various companies

Indrayani Biotech Ltd consolidated sales down 0.13% on year in Q2FY2026

07-Oct-26 21:24Hrs IST

Indrayani Biotech Ltd share price declined by 1.56% to Rs 10.08 after the company's net profit tumbled by 44.90% to Rs 0.54 crore, while revenue from operations eased by 0.13% to Rs 37.71 crore in Q2FY26 over Q1FY26.

The market capitalization of Other Agricultural Products industry group stocks on BSE stood at Rs 56512.32 crore, gaining 6.33%. It has inched up 1.34% over last one week and gained upto 1.75% in last one month while the market capitalization of Indrayani Biotech Ltd has softened by 0.49% and 29.89% in the same period respectively.

Profit before tax (PBT) of Indrayani Biotech Ltd stood at Rs 0.59 crore in Q2 FY26, expanding by 180.95% year-on-year, and tanking 153.15% quarter-on-quarter. EBITDA came in at Rs 0 crore, tumbling by 110.71% YoY and crashing by 109.02% sequentially.

Total expenses posted a minor rise of 1.77% to Rs 37.33 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 32.46 crore, surging by 28.45% YoY, while employee benefits expense was at Rs 2.92 crore, plunging by 32.09% YoY.

For the TTM ended FY26, revenue from operations slumped by 21.66% to Rs 130.23 crore, while net profit witnessed a sharp fall of 158.64% to Rs 6.11 crore, compared to previous TTM. EBITDA jumped by 2080% to Rs 3.13 crore, and PBT collapsed by 152.32% to Rs 5.74 crore compared to previous TTM.

The company's consolidated net cash flow from operating activities stood at Rs 6.74 crore in FY26, as against Rs 30.35 crore in FY25.

Indrayani Biotech Ltd crashed 26.06% in last one year, underperforming the benchmark BSE Sensex which has reduced by 10.66% during the same period.

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise